Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK4 | Q16654 | 1/20 | 0.51 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.49 |
| ▸ | GRM1 | Q13255 | 8/20 | 0.48 |
| ▸ | GRM5 | P41594 | 7/20 | 0.48 |
| ▸ | HTR6 | P50406 | 1/20 | 0.45 |
| ▸ | JAK1 | P23458 | 1/20 | 0.44 |
| ▸ | NAMPT | P43490 | 1/20 | 0.43 |
| ▸ | CNR1 | P21554 | 1/20 | 0.43 |
| ▸ | CDK9 | P50750 | 3/20 | 0.43 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.43 |
| ▸ | TNF | P01375 | 1/20 | 0.42 |
| ▸ | BTK | Q06187 | 1/20 | 0.42 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29744751 | 0.96 | PDK4 (0.54) | PDK4NR1H2GRM1GRM5HTR6 | |
| SCHEMBL6402391 | 0.96 | PDK4 (0.54) | PDK4NR1H2GRM1GRM5HTR6 | |
| SCHEMBL30822385 | 0.87 | PDK4 (0.54) | PDK4NR1H2GRM1GRM5HTR6 | |
| SCHEMBL27208421 | 0.87 | PDK4 (0.54) | PDK4NR1H2GRM1GRM5HTR6 | |
| SCHEMBL30120331 | 0.86 | NR1H2 (0.52) | PDK4NR1H2GRM1GRM5HTR6 | |
| SCHEMBL13993111 | 0.85 | GRM1 (0.57) | PDK4GRM1GRM5HTR6JAK1 | |
| SCHEMBL24310174 | 0.84 | PDK4 (0.55) | PDK4GRM1GRM5HTR6JAK1 | |
| SCHEMBL29566983 | 0.84 | PDK4 (0.55) | PDK4GRM1GRM5HTR6JAK1 | |
| SCHEMBL29744827 | 0.84 | PDK4 (0.55) | PDK4NR1H2GRM1GRM5HTR6 | |
| SCHEMBL1811363 | 0.84 | PDK4 (0.55) | PDK4NR1H2GRM1GRM5HTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4347044-A2 | EGFR DEGRADERS TO TREAT CANCER METASTASIS TO THE BRAIN OR CNS | C4 Therapeutics, Inc. (US) | 2024-04-10 | — | — | EP | disclosed |
| WO-2022251539-A2 | EGFR DEGRADERS TO TREAT CANCER METASTASIS TO THE BRAIN OR CNS | C4 THERAPEUTICS, INC. (US) | 2022-12-01 | — | — | WO | disclosed |
| EP-4076450-A1 | ISOINDOLINONE AND INDAZOLE COMPOUNDS FOR THE DEGRADATION OF EGFR | C4 Therapeutics, Inc. (US) | 2022-10-26 | — | — | EP | disclosed |